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SummARy – in this study, we investigated the impact of renal function, metabolic risk factors, 
and duration of diabetes on cataract development in patients with type 2 diabetes (t2dm). This study 
was cross-sectional and included 107 t2dm (67 male/40 female). Renal function was estimated with 
a creatinine-based formula (eGfR) and with albumin/creatinine (A/C) ratio. Patients were divided 
into three groups according to the lOCSiii classification: group 1 represents patients with clear 
crystalline lens (n=16), group 2 represent patients with initial cataract (n=74), and group 3 represents 
patients with immature cataract (n=17). Compared to group 1, group 3 had significantly longer diabe-
tes duration (17.12±6.38 vs. 10.81±4.09 years; p=0.004) and marginally higher hbA1c (7.11±1.41 vs. 
6.38±0.83%; p=0.057). diastolic blood pressure (dbP) was also significantly higher (90.94±15.41 vs. 
76.47±6.32 mmhg; p=0.002) while eGfR was significantly lower (53 ± 18 vs. 72 ± 12 ml/min-
11.73m-2; p=0.014). in logistic regression analysis, dbP (AOR=1.06, 95%Ci 1.00-1.12, p=0.039) and 
eGfR (AOR=3.02, 95%Ci 1.07-8.49, p=0.034) had a significant influence on cataract development 
even after adjustment for well-known risk factors hbA1c and duration of diabetes. The results of the 
study suggest a connection between renal function and cataract development in t2dm.
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nopathy (dR) is the most important preventable cause 
of vision loss in diabetes and nowadays the leading 
cause of blindness in the working-age populations3. 
Risk factors for dR are long duration of diabetes, in-
adequate glycemic control, hypertension, and diabetic 
nephropathy classified as reduced glomerular filtration 
rate (GfR) and/or increased albumin excretion rate 
(AeR). A possible explanation for this retinal−renal 
association is that similar structural changes and histo-
logical findings are seen in both chronic diabetic com-
plications4.
A cataract is also a frequent cause of blindness 
worldwide that can be prevented5. The characteristic of 
Introduction
diabetes prevalence is rapidly increasing world-
wide, affecting almost 500 million people in 20191. 
besides the risk of mortality (the seventh leading cause 
of death worldwide), chronic complications of diabetes 
lead to invalidity and reduction in quality of life and 
are also a burden on the health system2. diabetic reti-
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patients with diabetes is that cataract occurs earlier in 
life and also progresses faster than senile cataract, 
which causes earlier cataract surgery and risk of poorer 
vision outcome, especially if it is complicated with ac-
tive proliferative dR and/or preexisting diabetic mac-
ular edema6,7. The association between diabetes and 
cataract formation has been shown in basic researches 
as well as in clinical and epidemiological studies8,9. 
due to the increasing prevalence of diabetes world-
wide, the incidence of diabetic cataracts progressively 
rises and the clarification of pathogenesis and mecha-
nisms for preventing or delaying the development of 
cataracts in diabetic patients remains a challenge. Spe-
cific pathogenic mechanisms linking diabetes and lens 
opacification is not fully understood and probably in-
volves complications of diabetes and metabolic risk 
factors. A recently published study suggested for the 
first time that cataract become more common as renal 
function worsens10. besides, chronic kidney disease 
and major eye diseases, including cataracts, share com-
mon metabolic and vascular risk factors11. in this study, 
we investigated the impact of renal function, meta-
bolic risk factors, and duration of diabetes on cataract 
development in patients with type 2 diabetes (t2dm).
Patients and Methods
This cross-sectional study included 107 t2dm. Af-
ter an overnight fast, venous blood samples were col-
lected in order to determine metabolic risk factors: gly-
cated hemoglobin (hbA1c), and serum lipids (total, 
hdl, ldl cholesterol, and triglycerides). triglycerides 
and cholesterol in serum were measured by an enzy-
matic colorimetric method, while hbA1c was measured 
spectrophotometrically by turbidimetric immuno-inhi-
bition (Olympus Au600, beckman-Coulter, uSA).
blood pressure was measured minimally two times 
after a resting period of 10 minutes with a mercury 
sphygmomanometer. Renal function was determined 
using serum creatinine with a creatinine-based for-
mula (Chronic Kidney disease epidemiology Col-
laboration (CKd-ePi) formula) and with albumin/
creatinine (A/C) ratio12,13. A random urine sample was 
collected for assessment of the A/C ratio. urine albu-
min and creatinine levels were determined by turbidi-
metric immunoassay and photometric assays. A/C ra-
tio less than 3.0 mg/mmol was considered normal, 
micro-albuminuria was defined as any value between 
3.0 to 30.0 mg/mmol, and albuminuria more than 
30.0 mg/mmol was considered as macro-albuminuria. 
Patients had normal urine sediment without elements 
of urinary tract infections.
dR was determined according to the euROdi-
Ab retinal photography methodology with a trained 
ophthalmologist. eye examination of both eyes in-
cluded best corrected visual acuity (bCvA), biomi-
croscopy of the lens, fundoscopy, and color fundus 
photography14. According to the lens Opacity Clas-
sification System version iii (lOCSiii), patients were 
divided into three groups15.
local ethics committees have approved the study 
protocol, and the study has been conducted according 
to the declaration of helsinki and local institutional 
guidelines.
Statistical analysis was performed by Statistica soft-
ware package version 13.316. The Kolmogorov-Smirnov 
test was used to test the normality of data distribution 
and the leven test to test homogeneity of variance. Re-
sults of descriptive analyses were expressed as means ± 
Sd for continuous variables and as percentages for cat-
egorical variables. One-way AnOvA was used to test 
differences between continuous data, while the bonfer-
roni post hoc test was used where needed. The Chi-
square test was used to evaluate differences among cat-
egorical data. we used binary logistic regression analysis 
to investigate the associations between cataract and the 
other evaluated parameters. in all analyses, the p value 
of less than 0.05 was set as statistically significant.
Results
The study included 107 t2dm (67m/40f, aged 66 
years with a mean duration of diabetes of 15 years). in 
accordance with lOCSiii grading scales, we divided 
patients into three groups: group 1 represent patients 
with clear crystalline lens (n=16), group 2 represent 
patients with initial cataract (n=74), and group 3 rep-
resent patients with immature cataract (n=17) (table 
1). Comparing those three groups, patients have simi-
lar ages and a similar treatment for diabetes. Patients 
also had similar metabolic risk factors like systolic 
blood pressure (SbP) and all serum lipids. in the post 
hoc analyses, diabetes duration was significantly short-
er in group 1 compared to groups 2 and 3 (p=0.007; 
p=0.004), while hbA1c was marginally lower in groups 
1 and 2 compared to group 3 (p=0.053; p=0.057). Post 
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hoc analyses also showed that diastolic blood pressure 
(dbP) was significantly higher (p=0.002), dR signifi-
cantly more severe (p=0.047), and eGfR significantly 
lower (p=0.014) in group 3 compared to group 1. Sig-
nificant positive associations were observed between 
cataract and duration of diabetes, A/C ratio, dR, and 
dbP (p=0.002-0.009 for all) (table 2). Significant 
positive associations were also observed between dR 
and duration of diabetes, A/C ratio, triglycerides, and 
hbA1c (p<0.04 for all) (data not shown).
Results of univariate and multiple logistic regres-
sion analyses revealed that major risk factors for cata-
ract development in t2dm are hyperglycemia 
(OR=1.65, 95%Ci 1.07-2.53, p=0.022), duration of 
diabetes (OR=1.23, 95%Ci 1.07-1.41, p=0.003), dbP 
(OR=1.08, 95%Ci 1.03-1.13, p=0.002) and eGfR 
(OR=3.31, 95%Ci 1.34-8.22, p=0.008) (table 3). Af-
ter further adjustment for hbA1c and duration of dia-
betes, dbP (AOR=1.06, 95%Ci 1.00-1.12, p=0.039) 
and eGfR (AOR=3.02, 95%Ci 1.07-8.49, p=0.034) 
still stayed significantly associated with cataract devel-
opment.
Discussion
The results of this study suggest that the duration 
of diabetes, hyperglycemia, blood pressure, decreased 
renal function, and the presence of dR are involved in 
cataract development in t2dm. in addition, in logis-
tic regression analyses after adjustment for hbA1c and 
duration of diabetes, effects of dbP and renal function 
Table 1. Basic characteristics, metabolic risk factors, blood pressure, diabetic retinopathy, and renal function parameters 







Age (years)* 66.31 ± 8.31 68.47 ± 7.11 66.52 ± 7.98 0.583a
Sex (f/m)** 31.3 / 68.75 39.2 / 60.81 35.3 / 64.7 1.000b
diabetes duration (years)* 10.81 ± 4.09 15.49 ± 5.43 17.12 ± 6,38 <0.001a
diabetes treatment (OhA/insulin)** 7 / 9 25 / 49 8 / 9 1.000b
hbA1c (%)* 6.38 ± 0.83 6.38 ± 1.06 7.11 ± 1.41 0.052a
total cholesterol (mmol/l)* 4.87 ± 1.28 4.88 ± 0.83 5.43 ± 1.14 0.117a
hdl cholesterol (mmol/l)* 1.37 ± 0.19 1.36 ± 0.35 1.29 ± 0.35 0.691a
ldl cholesterol (mmol/l)* 2.71 ± 1.09 2.62 ± 0.80 3.03 ± 0.98 0.245a
triglycerides (mmol/l)* 1.89 ± 1.02 2.23 ± 1.41 2.91 ± 0.23 0.540a
Systolic blood pressure (mmhg)* 134.06 ± 21.15 143.65 ± 22.58 144.41 ± 20.38 0.297a
diastolic blood pressure (mmhg)* 76.47 ± 6.32 80.00 ± 11.96 90.94 ± 15.41 0.001a
Serum creatinine (umol/l)* 95.25 ± 7.28 109.28 ± 19.53 122.41 ± 41.43 0.249a
eGfR (ml/min-11.73m-2)* 72 ± 12 60 ± 11 53 ± 18 0.017a
A/C ratio (mg/mmol)* 10.04 ± 17.01 14.45 ± 34.61 15.44 ± 16.39 0.850a
bCvA (decimal)* 0.97 ± 0.10 0.91 ± 0.19 0.84 ± 0.34 0.207a
diabetic retinopathy (dR)** 81.2 / 6.3 / 12.5 62.2 / 17.6 / 20.2 35.3 / 29.4 / 35.3 0.023b
* mean ± Sd ** percentages a one-way AnOvA b Chi-square test
Abbreviations: OhA: oral hypoglycemic agent; hbA1c: glycated hemoglobin value; eGfR estimated glomerular filtration rate; A/C ratio: 
albumin/ creatinine ratio; bCvA: best corrected visual acuity; dR: no retinopathy / mild-moderate nonproliferative dR / severe nPdR-
proliferative dR.
Table 2. Correlation between cataract and diabetes 
duration, albumin/creatinine ratio, diastolic blood 
pressure, and retinopathy in type 2 diabetes (n=107).
Cataract
Spearman R t(N-2) p
diabetes duration 
(years) 0.299 3.219 0.002
diastolic blood 
pressure (mmhg) 0.298 3.203 0.002
A/C ratio (mg/mmol) 0.196 2.049 0.042
diabetic retinopathy 0.249 2.640 0.009
Abbreviation: A/C ratio: albumin/creatinine ratio
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presented by eGfR on cataract development was still 
significant. in patients with diabetes relationship be-
tween ocular and renal disease are more frequent in 
t2dm than type 1 diabetes17. visual impairment is 
often associated with the progression of renal disease 
because there are several pathogenic mechanisms un-
derlying both chronic kidney and eye disease11,18. in 
addition, the structure of the kidney and the eye are 
similar, as well as developmental processes with the 
same transcription factors and epithelial cells (retinal 
or glomerular) overlying a basement membrane of col-
lagen iv and capillary19.
Cortical, nuclear, and posterior subcapsular cata-
racts are morphologically three main cataract types, 
whereas etiologically, the most common is the age-re-
lated cataract. The pathophysiology of cataract is not 
wholly understood and include age, genetic, nutrition-
al, environmental, ultraviolet light exposure, and sys-
temic factors20. The results of previous studies investi-
gating the association between chronic kidney disease 
and cataract formation or progression vary consider-
ably. The first large population-based study published 
in 1998 and investigating the 5-year incidence of cata-
ract and renal function concluded that renal function 
is not associated with cataract after adjusting for gen-
der and age21. however, after the extension of the same 
study over a 15-year interval, investigators found a sig-
nificant association between renal function (measured 
with cystatin C, serum urea, and creatinine) with an 
incidence of posterior subcapsular and cortical cata-
ract22. it should be stressed that serum cystatin C is a 
more sensitive marker of glomerular filtration com-
pared to serum creatinine in patients with mildly im-
paired renal function, and patients in our study had 
normal or mildly impaired renal function23. Another 
population-based prospective study found that pa-
tients with eGfR below 60 ml/min-11.73m-2 had a 
higher incidence of cataract surgery compared to pa-
tients with eGfR over 60 ml/min-11.73m-2 24. A case-
control study based on the health insurance database 
found an increased incidence of cataract in patients 
with nephropathy25.
The possible mechanism for cataract formation in 
chronic renal disease is the deposition of urea and wa-
ter in the lens leading to the development of an os-
motic cataract26. besides, in patients with diabetes, 
oxidative stress is increased in chronic kidney disease 
inducing cataract formation27. Other mechanisms un-
derlying cataracts in chronic kidney disease include 
endothelial dysfunction, atherosclerosis, inflammation, 
vitamin d deficiency, renin-angiotensin system dys-
function, anemia associated with nephropathy, and hy-
pocalcemia11,28. moreover, nearly two-thirds of pa-
tients with diabetes have evidence of cataracts, mainly 
mixed cataracts6. Recently published retrospective 
analysis of data from a public health system of patients 
who had accessed cataract surgery confirmed previ-
ously suggested assumption that cataracts are more 
common as renal failure worsens10. Patients with 
chronic kidney disease had an almost two-fold higher 
risk of cataract development after correcting for co-
morbidities, and risk is further increased in patients 
with advanced kidney failure. Chronic kidney disease 
increases the risk of bilateral cortical and posterior 
subcapsular cataracts5. Although cataract is increased 
in some other conditions closely connected with 
Table 3. Risk factors and predictors for the development of cataract by means of univariate and multiple 
logistic regression analyses.
Variable OR (95% CI) P AOR (95% CI)* P*
diabetes duration 1.23 (1.07-1.41) 0.003 / /
hbA1c 1.65 (1.07-2.53) 0.022 / /
Systolic blood pressure 1.02 (0.99-1.04) 0.122 1.02 (0.99-1.05) 0.204
diastolic blood pressure 1.08 (1.03-1.13) 0.002 1.06 (1.00-1.12) 0.039
Serum creatinine 1.02 (0.99-1.04) 0.151 1.00 (0.98-1.04) 0.457
eGfR 3.31 (1.34-8.22) 0.008 3.02 (1.07-8.49) 0.034
A/C ratio 1.00 (0.98-1.03) 0.580 1.01 (0.98-1.03) 0.864
* OR after adjustment for diabetes duration and hbA1c
Abbreviation: hbA1c: glycated hemoglobin value; eGfR: estimated glomerular filtration rate; A/C ratio: albumin/creatinine 
ratio.
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chronic kidney disease like diabetes, hypertension, 
smoking, obesity, and dyslipidemia, multivariate analy-
ses confirmed that renal dysfunction is a strong and 
independent risk factor for cataract development11. 
besides hyperglycemia, albuminuria is also a risk factor 
for cataract development even in those with a short 
duration of diabetes and in those with newly diag-
nosed diabetes6. in those with prolonged diabetes, hy-
perglycemia induces modification of the lens proteins 
with the ACe formation or modification of the 
AtPase pumps with osmotic stress contributing to 
cataract formation29.
This study has some potential limitations. first, the 
small number of patients with clear crystalline lenses 
and those with immature cataracts makes it difficult to 
generalize our results. Second, the results would be 
primarily referred to as a white european population. 
Third, selection bias is likely because our study was 
conducted in a hospital. fourth, several risk factors in-
volved in the development of cataract, such as sunlight 
exposure and nutritional history, were not considered.
in conclusion, this study’s results suggest that renal 
function parameters, primarily A/C ratio and eGfR, 
are involved in cataract development in t2dm with 
traditional risk factors like duration of diabetes, 
hbA1c, and dbP. in order to prevent chronic kidney 
disease, cataract development, and disability, and sur-
gery related to cataract, strict control of risk factors is 
needed.
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Sažetak
bubReŽnA funKCiJA Je POveZAnA S RAZvOJem KAtARAKte  
u bOleSniKA SA ŠeĆeRnOm bOleŠĆu tiPA 2
Martina Tomić, Romano Vrabec, Spomenka Ljubić, Tomislav Bulum, Ingrid Prkačin i Dario Rahelić
Cilj istraživanja bio je istražiti utjecaj trajanja šećerne bolesti (Šb), metaboličkih rizičnih čimbenika i bubrežne funkcije 
na razvoj katarakte u bolesnika sa šećernom bolešću tipa 2 (Šb2). Ovo presječno istraživanje je uključilo 107 bolesnika sa Šb2 
(67 muškaraca/40 žena). bubrežna funkcija je procijenjena određivanjem glomerularne filtracije (Gf) i omjerom albumin/
kreatinin (A/K) u urinu. bolesnici su prema lOCS iii bili podijeljeni u tri skupine: sk. 1 - bolesnici s prozirnom očnom 
lećom (n=16), sk. 2 - bolesnici s početnom kataraktom (n=74) i sk. 3 - bolesnici s nezrelom kataraktom (n=17). bolesnici u 
sk. 3 imali su značajno duže trajanje Šb (17.12±6.38 vs. 10.81±4.09 godina; p=0.004) i granično viši hbA1c (7.11±1.41 vs. 
6.38±0.83%; p=0.057) nego oni u sk. 1. dijastolički krvni tlak (dKt) bio je značajno viši (90.94±15.41 vs. 76.47±6.32 
mmhg; p=0.002), a procijenjena Gf značajno niža (53±18 vs. 72±12 mlmin-11.73m-2; p=0.017) u sk. 3 nego u sk. 1. logistič-
ka regresija je utvrdila da su dKt (AOR=1.06, 95%Ci 1.00-1.12, p=0.039) i Gf (AOR=3.02, 95%Ci 1.07-8.49, p=0.034) 
povezani s razvojem katarakte u Šb2 čak i nakon standardizacije rezultata za trajanje Šb i hbA1c. Rezultati ovog istraživanja 
su pokazali da bubrežna funkcija ima važnu ulogu u razvoju katarakte u Šb2.
Ključne riječi: Katarakta; Šećerna bolest tipa 2; Krvni tlak; Bubrežna funkcija
